Extracorporeal respiratory support (ECMO / ECCO₂R)
ECMO · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
ECMO: high-flow veno-venous (respiratory) or veno-arterial (cardiac) circuit through a membrane oxygenator taking over gas exchange, letting the lungs “rest” on non-injurious settings. ECCO₂R: lower-flow veno-venous CO₂ removal permitting ultra-protective ventilation.
Red flags
- Bleeding (including intracranial) is the defining complication — examine pupils daily
- Differential hypoxaemia (Harlequin) on VA-ECMO — check RIGHT radial gases
Management
- Consider VV-ECMO for potentially reversible severe ARDS failing optimised conventional care (prone, paralysis, PEEP): e.g. P/F <10 kPa (80 mmHg) >6 h, or <7 kPa >3 h, or pH <7.25 with pCO₂ ≥8 despite optimisation (EOLIA criteria)
- Refer/retrieve to an ECMO centre EARLY — transfer on conventional ventilation is the usual UK model (CESAR)
- Relative contraindications: prolonged high-pressure ventilation >7 days, severe chronic organ disease, uncontrolled bleeding, unsurvivable injury
- On circuit: rest settings, anticoagulation, daily neurological and limb checks, vigilance for bleeding and circuit clot
- ECCO₂R: adjunct for hypercapnic acidosis on ultra-protective ventilation (specialist units)
Exam pearls
- 2020s update: CESAR (2009) and EOLIA (2018) underpin modern referral criteria; survival in referred severe ARDS ~60%+ in experienced centres
The right question is not “can we ECMO here?” but “should this patient be in an ECMO centre?” — ask early.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.